Filing Flows

Filing Flows › Scientific Industries (SCND) › Q4 2025

Scientific Industries (SCND) Q4 2025 earnings results (fourth quarter 2025)

10-K filed Mar 31, 2026

Scientific Industries (SCND) reported revenue of $1.6M for the fourth quarter 2025 (Q4 2025), +27% from a year earlier and +16% from the quarter before. Operating margin was -150.9%, net loss $2.5M (152.0% of revenue).

Revenue$1.6M
Year over year+27%
Quarter over quarter+16%
Operating margin-150.9%
Net earnings−$2.5M

Scientific Industries, Q4 2025: revenue $1.6M (+27% year over year), operating margin -150.9%, net loss $2.5M, operating cash flow −$3.8M. The chart follows the revenue to costs, profit and cash.

Q4 2025AmountQ/QY/Y
Revenue$1.6M+16%+27%
Operating profit−$2.5M——
Net earnings−$2.5M-162%—
Operating cash flow−$3.8M——

What changed

Revenue was $1.6M in Q4 2025, up 27% year over year and up 16% from the previous quarter. Benchtop Laboratory Equipment was the largest line at 63% of revenue.

Operating costs exceeded revenue by $2.5M, an operating margin of -150.9%. The quarter ended with a net loss of $2.5M, after a profit of $4.0M the previous quarter. Minority interests bore $560K of it: to shareholders the quarter was a loss of $1.9M. Non-operating items added $532K, -28% of pre-tax earnings, so the bottom line overstates operating performance.

Operating cash flow was −$3.8M. Non-cash charges added back $152K of depreciation and amortization and $73K of share-based compensation. Working capital and other items used $1.5M. Capital expenditures of $20K exceeded it, leaving free cash flow of −$3.8M.

Questions

What was Scientific Industries' revenue in the fourth quarter 2025?

Scientific Industries (SCND) reported revenue of $1.6M for the fourth quarter 2025 (Q4 2025), +27% from a year earlier and +16% from the quarter before.

Was Scientific Industries profitable in the fourth quarter 2025?

Operating loss was $2.5M (-150.9% of revenue) and net loss $2.5M.

Open the interactive Sankey →

Source: Scientific Industries 10-K on SEC EDGAR.